Peers & Perspectives in Oncology
February II, 2024
Volume: 2
Issue: 3
February I, 2024
Volume: 2
Issue: 2
January 2024
Volume: 2
Issue: 1
December II, 2023
Volume: 1
Issue: 11
December I, 2023
Volume: 1
Issue: 10
November II, 2023
Volume: 1
Issue: 9
November I, 2023
Volume: 1
Issue: 8
October II 2023
Volume: 1
Issue: 7
October I 2023
Volume: 1
Issue: 6
September 2023
Volume: 1
Issue: 5
August 2023
Volume: 1
Issue: 4
July II 2023
Volume: 1
Issue: 3
July I 2023
Volume: 1
Issue: 2
June 2023
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
